ERBB2 and breast cancer: Denkert et al. also reported that HER2-low breast cancers tended to show higher hormone receptor expression levels, lower cell proliferation, and lower tumor grade compared to HER2-zero breast cancers in a pooled analysis of 2,310 patients [24].